Item 8.01 Other Events.

On May 28, 2021, Verrica Pharmaceuticals Inc. (the "Company") issued a press release announcing the extension of the U.S. Food and Drug Administration review period of its New Drug Application for VP-102. The Prescription Drug User Fee Act goal date has been extended by three months to September 23, 2021.

A copy of the press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits



Exhibit
Number                                   Exhibit Description

99.1           Press Release

104          Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses